Brainstorm Cell Therapeutics (BCLI) Cash & Equivalents (2010 - 2026)
Brainstorm Cell Therapeutics' Cash & Equivalents came in at $22,000 for Q2 2026, down 97.3% from $824,000 a year earlier but up 46.7% from the prior quarter.
Powered by 
Analysis
Brainstorm Cell Therapeutics (BCLI) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Brainstorm Cell Therapeutics' Cash & Equivalents was $29,000, down 84.5% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of -76.2% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $187,000 in FY2024 (-85.6%), $1.3 million in FY2023 (+68.4%), $772,000 in FY2022 (-95.9%) and $18.86 million in FY2021 (-50.2%).
- The five-year range for quarterly Cash & Equivalents is $5,000 (Q3 2025) to $25.7 million (Q3 2021).
- Year-over-year, Cash & Equivalents has declined for five consecutive quarters, with an average decline of 64.4% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q2 2024 (growth of 535.3%), and the weakest in Q1 2026 (a decline of 99.1%).
- Business Quant data shows BCLI's Cash & Equivalents at $15,000 (Q1 2026), $29,000 (Q4 2025) and $5,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.49 Bn | 1,099.07 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.65 Bn | 555.51 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 505.44 Bn | 478.55 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.27 Bn | 312.65 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 291.57 Bn | 255.56 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.15 Bn | 238.84 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.41 Bn | 192.81 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 195.01 Bn | 169.21 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.23 Bn | 117.87 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Brainstorm Cell Therapeutics | 8.39 Mn | 8.32 Mn | - | 22,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22,000.00 |
| Mar 31, 2026 | 15,000.00 |
| Dec 31, 2025 | 29,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 824,000.00 |
| Mar 31, 2025 | 1.64 Mn |
| Dec 31, 2024 | 187,000.00 |
| Sep 30, 2024 | 168,000.00 |
| Jun 30, 2024 | 3.47 Mn |
| Mar 31, 2024 | 779,000.00 |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 1.22 Mn |
| Jun 30, 2023 | 546,000.00 |
| Mar 31, 2023 | 2.02 Mn |
| Dec 31, 2022 | 772,000.00 |
| Sep 30, 2022 | 4.14 Mn |
| Jun 30, 2022 | 9.01 Mn |
| Mar 31, 2022 | 15.15 Mn |
| Dec 31, 2021 | 18.86 Mn |
| Sep 30, 2021 | 25.70 Mn |
API Access
Brainstorm Cell Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BCLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "BCLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BCLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();